Lyka Labs Ltd.
LYKALABS Share PricePharmaceuticals & Drugs
₹98.9
-0.5 (-0.5%)
As on September 8, 2025
Exchange Scrips: BSE500259NSELYKALABSISININE933A01014
Market Cap ₹ 353 Cr
P/E Ratio 44.06
Dividend Yield N/A
Performance
Market performance
Open99
High100.76
Volumes19,569
Prev98.9
Low98.5
As on2025-09-08
Historical performance
1 Year High176.59
3 Year High176.59
5 Year High267
1 Year Low96.8
3 Year Low88.5
5 Year Low16
Fundamentals
Company Valuation
Market Cap (₹Cr)
353
Face Value (₹)
10
P/E Ratio
44.06
Dividend Yield
N/A
Investment Returns
1 Year
-39.9%
3 Years
-33.6%
5 Years
423.3%
10 Years
44.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 99.99 | Bearish |
| 10-DMA | 99.97 | Bearish |
| 20-DMA | 100.62 | Bearish |
| 50-DMA | 107.36 | Bearish |
| 100-DMA | 110.89 | Bearish |
| 200-DMA | 123.09 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 14 | 12 | 10 | 10 | 10 |
| Foreign Investors | --- | --- | --- | --- | --- |
| Domestic Investors | 14 | 12 | 10 | 10 | 10 |
| Public Investors | 28175 | 28460 | 29089 | 28933 | 25706 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 44.06.
- 3Y Stock Price CAGR of the stock is -12.2.
- The stock has a beta of 1.1.
- In the last financial year, the company had an EBITDA of ₹202 Million.
- The company generated revenue of ₹1385 Million in the previous financial year.
Lyka Labs Ltd.
98.9-0.5 (-0.5%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 635399.9
No. of Shares: 6425 (Approx)
Performance:-36.5%
P/L: ₹-364600.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent